Richard A. Heyman
Director · 4 filings · Latest: Feb 17, 2026
Enliven Therapeutics, Inc.
Oric Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ELVN | Richard A. Heyman | Director | Feb 17, 2026 | Sale | $26.18 | 1,230 | $32.2K | 22,647 | |
ELVN | Heyman Richard A. | — | Feb 17, 2026 | Proposed Sale | $26.72 | 1,230 | $32.9K | — | |
ELVN | Richard A. Heyman | Director | Jan 20, 2026 | Sale | $26.75 | 1,230 | $32.9K | 23,877 | |
ORIC | Richard A. Heyman | Director | Jan 16, 2026 | Sale | $12.00 | 6,700 | $80.4K | 213,072 | |
ELVN | Heyman Richard A. | — | Jan 20, 2026 | Proposed Sale | $26.71 | 1,230 | $32.9K | — | |
ORIC | Richard A, Heyman | — | Jan 16, 2026 | Proposed Sale | $12.00 | 6,400 | $76.8K | — | |
ORIC | Richard A, Heyman | — | Jan 16, 2026 | Proposed Sale | $12.00 | 7,000 | $84.0K | — | |
ELVN | Heyman Richard A. | — | Jan 8, 2026 | Proposed Sale | $15.47 | 1,620 | $25.1K | — | |
ELVN | Heyman Richard A. | — | Jan 8, 2026 | Proposed Sale | $15.47 | 12,300 | $190.3K | — | |
ELVN | Heyman Richard A. | — | Oct 18, 2024 | Proposed Sale | $28.02 | 1,566 | $43.9K | — | |
ELVN | Heyman Richard A. | — | Oct 18, 2024 | Proposed Sale | $28.02 | 12,165 | $340.9K | — | |
ELVN | Heyman Richard A. | — | Oct 15, 2024 | Proposed Sale | $27.75 | 1,270 | $35.2K | — | |
ELVN | Heyman Richard A. | — | Oct 4, 2024 | Proposed Sale | $25.51 | 2,540 | $64.8K | — |